Department of Pathological Anatomy

Medicine & Life Sciences

1. Indonesia 100%
2. Breast Neoplasms 42%
3. Neoplasms 42%
4. Uterine Cervical Neoplasms 28%
5. Colorectal Neoplasms 23%
6. Neoplasm Metastasis 20%
7. Carcinoma 20%
8. Immunohistochemistry 19%
9. Dextran Sulfate 18%
10. Staining and Labeling 17%
11. Colon 17%
12. Lymphoma 15%
13. Skin Neoplasms 15%
14. Bone and Bones 15%
15. Cell Line 15%
16. Apoptosis 14%
17. Squamous Cell Carcinoma 14%
18. Caspase 3 14%
19. Biopsy 13%
20. Lymphoma, Large B-Cell, Diffuse 13%
21. Lymph Nodes 13%
22. Japan 12%
23. Pleural Empyema 12%
24. Proteins 12%
25. Drug Therapy 12%
26. Human Herpesvirus 4 12%
27. Liver 11%
28. Ethanol 11%
29. Control Groups 11%
30. T-Cell Lymphoma 10%
31. Catenins 10%
32. Adenocarcinoma 10%
33. Carcinogenesis 10%
34. Cell Biology 9%
35. Therapeutics 9%
36. Paraffin 9%
37. Inflammation 9%
38. Survival 9%
39. Pathology 9%
40. Mutation 9%
41. Osteosarcoma 9%
42. B-Lymphocytes 8%
43. Melanoma 8%
44. Giant Cell Tumor of Bone 8%
45. Sarcoma 8%
46. Hepatocellular Carcinoma 8%
47. Anti-Inflammatory Agents 8%
48. Mesenchymal Stem Cells 8%
49. Fibrosis 8%
50. Ductal Carcinoma 7%
51. Cyclooxygenase 2 7%
52. Recurrence 7%
53. Sprague Dawley Rats 7%
54. Case-Control Studies 7%
55. Polyps 7%
56. Population 7%
57. Annona 7%
58. antimycin 7%
59. Cell Proliferation 7%
60. Epidemiologic Studies 7%
61. Azoxymethane 7%
62. Giant Cell Tumors 7%
63. Incidence 7%
64. Tuberculosis 7%
65. Skin 7%
66. Fruit 7%
67. Wistar Rats 7%
68. Lymphocytes 7%
69. Genes 6%
70. Breast 6%
71. Chronic Hepatitis B 6%
72. Basal Cell Carcinoma 6%
73. Eosine Yellowish-(YS) 6%
74. Curcumin 6%
75. Cross-Sectional Studies 6%
76. Endometrioid Carcinoma 6%
77. Chitosan 6%
78. Natural Killer Cells 6%
79. Embryonal Rhabdomyosarcoma 6%
80. Pomegranate 6%
81. Neoplastic Stem Cells 6%
82. Keratin-19 6%
83. In Vitro Techniques 6%
84. nucleolar organizer region associated proteins 6%
85. Cancer-Associated Fibroblasts 6%
86. Cadherins 6%
87. Radiotherapy 6%
88. Hematoxylin 6%
89. Rhabdomyosarcoma 6%
90. DNA 6%
91. Sensitivity and Specificity 6%
92. Wounds and Injuries 6%
93. Mitosis 6%
94. Epidemiology 6%
95. Cancer Care Facilities 6%
96. Wound Healing 5%
97. General Hospitals 5%
98. Fetal Blood 5%
99. Polymerase Chain Reaction 5%
100. Biomarkers 5%